Clinical Trial Update: Spironolactone Therapy In Young Women With NASH [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating spironolactone for nonalcoholic steatohepatitis in young women has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: University of California, San Francisco | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-26